Akinaga et al., "Antitumor Effect of KT6124, A Novel Derivative of Protein Kinase Inhibitor K-252A, and Its Mechanism of Action", Cancer Chemother. Pharmacol. 29:266-272 (1992). |
Berg et al., "K-252a Inhibits Nerve Growth Factor-Induced trk Photo-Oncogene Tyrosine Phosphorylation and Kinase Activity", J. Biological Chem. 267:13-16 (1992). |
Brocker et al., "Nerve Growth and Expression of Receptors for Nerve Growth Factor in Tumors of Melanocyte Origin", J. Investigative Dermatology 96:662-665 (1991). |
Cunha et al., "Normal and Abnormal Development of the Male Urogenital Tract", J. Andrology, 13:465-475 (1992). |
Djakiew et al., "Regulation of Growth by a Nerve Growth Factor-Like Protein Which Modules Paracrine Interactions Between a Neoplastic Epithelial Cell Line . . . , " Cancer Research 51:3304-3310 (1991). |
Elliott et al., "K252a is a Potent and Selective Inhibitor of Phosphorylase Kinase", Biochemical and Biophysical Research Communications 171:148-154 (1990). |
Hashimoto et al., "Blockage of Nerve Growth Factor Action in PC12h Cells by Staurosporine, A Potent Protein Kinase Inhibitor", J. Neurochemistry 53:1675-1685 (1989). |
Hempstead et al., "Overexpression of the trk Tyrosine Kinase Rapidly Accelerates Nerve Growth Factor-Induced Differentiation", Neuron 9:883-896 (1992). |
Mac Morgan et al., "Expression of Nerve Growth Factor and Nerve Growth Factor Receptor Genes in Human Tissues and in Prostatic Adenocarcinoma Cell Lines", J. Neurochemistry, 59:1381-1390 (1992). |
Nakagawa et al., "Association Between High Levels of Expression of the trk Gene and Favorable Outcome in Human Neuroblastoma", New England J. Medicine 328:847-854 (1993). |
Nye et al., "K-252a and Staurosporine Selectively Block Autophosphorylation of Neurotrophin Receptors and Neurotrophin-Mediated Responses", Molecular Biology of the Cell 3:677-686 (1992). |
Tapley et al., "K252a is a Selective Inhibitor of the Tyrosine Protein Kinase Activity of the trk Family of Oncogenes and Neurotrophin Receptors", Oncogene 7:371-381 (1992). |
Morton et al., "Differential Effects of Growth Factor Antagonists on Neoplastic and Normal Prostatic Cells", The Prostate 17:327-336 (1990). |
Ichikawa et al., "The Antitumor Effects of Quinoline-3-Carboxamide Linomide on Dunning R-3327 Rat Prostatic Cancers", Cancer Research 52:3022-3028 (1992). |
Issacs et al., "Establishment and Characterization of Seven Dunning Rat Prostatic Cancer Cell Lines and Their Use in Developing Methods for Predicting . . . ", The Prostate 9:261-281 (1986). |
Eisenberger et al., "Suramin, An Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial", J. of Nat. Cancer Institute 85:611-621 (1993). |
Bozyczko-Coyne et al., "A Rapid Fluorometric Assay to Measure Neuronal Survival in Vitro", Journal of Neuroscience Methods, 50:205-216 (1993). |
Hughes et al., "Synthesis of the Indolo[2,3-A]Carbazole Natural Products Staurosporinone and Arcyiaflavin B", J. Chem. Soc. Perkin Trans. 1:2475-2480 (1990). |
Hirata et al., Chemical Abstracts, vol. 111, No. 21, Issued Nov. 20, 1989, Abstract 194456g. |
Tishler et al., Chemical Abstracts, vol. 113, No. 21, Issued Nov. 19, 1990. |